Clear cell renal carcinoma (ccRCC) is a heterogeneous disease with a variable post-
surgical course. To assemble a comprehensive ccRCC tumor microenvironment (TME) …

Active surveillance of renal masses, which includes serial imaging with the possibility of
delayed treatment, has emerged as a viable alternative to immediate therapeutic …

Dysregulation of fatty acid metabolism and de novo lipogenesis is a key driver of several
cancer types through highly unsaturated fatty acid (HUFA) signaling precursors such as …

The clinical presentation of renal cell cancer (RCC) is shifting towards incidental and early
detection, creating new challenges in RCC diagnosis. Overtreatment might be reduced with …

Primary hepatocellular carcinoma (HCC) is one of the most frequently occurring pernicious
tumors in the world. It is typically very insidious in the early stages with no obvious …

Simple Summary Current imaging techniques do not reliably distinguish renal cell
carcinoma from other renal diseases. This review summarizes recent advances in other …

Simple Summary Early detection of renal cell carcinoma (RCC) significantly increases the
likelihood of curative treatment, avoiding the need of adjuvant therapies, associated side …

The major invasive subtype of kidney cancer is renal cell carcinoma (RCC). The essential
components of cancer development are chronic inflammation and neoangiogenesis. It has …

Objectives To review urinary protein biomarkers as potential non‐invasive, easily
obtainable, early diagnostic tools in renal cell carcinoma (RCC). Methods A PubMed …

The treatment of metastatic renal cell carcinoma has significantly evolved in recent years,
particularly with the advent of novel immune checkpoint inhibitors (ICI). Despite the striking …